Carolinas Wealth Consulting’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-51
Closed -$6.06K 992
2025
Q1
$6.06K Hold
51
﹤0.01% 579
2024
Q4
$5.89K Buy
51
+28
+122% +$3.54K ﹤0.01% 616
2024
Q3
$3.08K Buy
23
+1
+5% +$134 ﹤0.01% 737
2024
Q2
$2.93K Sell
22
-1
-4% -$136 ﹤0.01% 729
2024
Q1
$2.92K Buy
23
+1
+5% +$121 ﹤0.01% 732
2023
Q4
$2.47K Hold
22
﹤0.01% 716
2023
Q3
$2.02K Sell
22
-39
-64% -$4.02K ﹤0.01% 745
2023
Q2
$6.89K Sell
61
-8
-12% -$846 ﹤0.01% 639
2023
Q1
$7.22K Buy
69
+27
+64% +$2.82K ﹤0.01% 649
2022
Q4
$4.64K Buy
+42
New +$4.4K ﹤0.01% 702

Other funds holding XYL

Carolinas Wealth Consulting's XYL Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Xylem (XYL) in Q2 2025, closing a stake of 51 shares — an estimated $6.06K sold.

Carolinas Wealth Consulting first reported a position in XYL in Q4 2022 and held it in 10 quarters. The position peaked at $7.22K in Q1 2023. 1,063 funds tracked by Wall St. Rank hold XYL as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Xylem position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 51 Xylem shares in Q2 2025, an estimated $6.06K.
  • Carolinas Wealth Consulting first reported a position in Xylem in Q4 2022 and held it in 10 quarters.
  • Carolinas Wealth Consulting's Xylem position peaked at $7.22K in Q1 2023.
  • 1,063 funds tracked by Wall St. Rank held Xylem as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.